Because of the medication’s politicization, and the pernicious tendency for dissenting perspectives to be silenced during the pandemic, data supporting hydroxychloroquine’s effectiveness have been almost inaudible. But a recent analysis pooling together results of randomized clinical trials testing hydroxychloroquine’s use in early COVID-19 infection should substantially raise the volume.